Maravai Lifesciences Holdings Inc. Insider Trading

MRVI

⊜ Compare

Last 12 months

Insiders bought $1.88M and sold 254K on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

+$1.63M

3 buys · 1 sale

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

2 / 1

executives and directors

Last open-market buy

Dec 2025

Dec 8, 2025

Get an email when MRVI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 9 – 10	Kurt Oreshack General Counsel	Sold10b5-1 plan 2 parts	50,000	$5.08 average	254K	13%	Form 4
Dec 5, 2025 – Dec 8, 2025	Gregory T Lucier Director	Bought 2 parts	100,000	$3.69 average	369K	61%	Form 4
Nov 13, 2025	Bernd Brust Chief Executive Officer	Bought	216,212	$3.25	703K	9.6%	Form 4
Nov 11, 2025 – Nov 12, 2025	Bernd Brust Chief Executive Officer	Bought 2 parts	250,559	$3.23 average	809K	13%	Form 4
Jan 31, 2025	Kurt Oreshack General Counsel	Sold10b5-1 plan	25,000	$5.03	126K	13%	Form 4
Nov 12, 2024	John A Deford Director	Bought	17,500	$5.75	101K	33%	Form 4
Nov 11, 2024	Carl Hull See Remarks	Bought	175,000	$5.64	987K	58%	Form 4

Jun 9 – 1010b5-1 plan
Kurt Oreshack
General Counsel · sold 50,000 at avg $5.08
254K
13% of stake
Dec 5, 2025 – Dec 8, 2025
Gregory T Lucier
Director · bought 100,000 at avg $3.69
369K
61% of stake
Nov 13, 2025
Bernd Brust
Chief Executive Officer · bought 216,212 at $3.25
703K
9.6% of stake
Nov 11, 2025 – Nov 12, 2025
Bernd Brust
Chief Executive Officer · bought 250,559 at avg $3.23
809K
13% of stake
Jan 31, 202510b5-1 plan
Kurt Oreshack
General Counsel · sold 25,000 at $5.03
126K
13% of stake
Nov 12, 2024
John A Deford
Director · bought 17,500 at $5.75
101K
33% of stake
Nov 11, 2024
Carl Hull
See Remarks · bought 175,000 at $5.64
987K
58% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MRVI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MRVI

CompareIntrinsic value

VNDAVanda Pharmaceuticals Inc.

$3.88+3.47%10

IDYAIdeaya Biosciences Inc.

$32.36+3.29%40

AKBAAkebia Therapeutics Inc.

$0.69-4.31%49

SLNOSoleno Therapeutics Inc

No recent price25

URGNUrogen Pharma Ltd.

$28.71-16.54%30

CYRXCryoport Inc.

$16.70+1.52%13

PBYIPuma Biotechnology Inc.

$10.69+4.60%68

AMRNAmarin Corp PLC\Uk

$12.25+1.66%46

Held by ETFs

MRVI is in 27 US ETFs. The largest of them, with MRVI's weight in each:

Spot a number that looks wrong? Check it in MRVI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MRVI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.